home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

88.85 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

72 73 Next >

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

November 13, 2022

From BioNTech SE

Via GlobeNewswire

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows ↗

November 11, 2022

Via Benzinga

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

November 10, 2022

By Ernest Dela Aglanu, Benzinga

Via News Direct

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

November 10, 2022

Learn more about Organicell Regenerative Medicine, Inc.from this latest report.

Via TheNewswire.com

This COVID-19 Vaccine Stock Has More to Offer ↗

November 10, 2022

The vaccine revenue was nice, but it's time to look ahead.

Via The Motley Fool

BioNTech SE (BNTX) Q3 2022 Earnings Call Transcript ↗

November 07, 2022

BNTX earnings call for the period ending September 30, 2022.

Via The Motley Fool

Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster ↗

November 10, 2022

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

November 10, 2022

From BioNTech SE

Via GlobeNewswire

2 Top Healthcare Stocks to Buy Right Now ↗

November 10, 2022

These two dividend stocks offer 3%-plus dividend yields that are secure.

Via The Motley Fool

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier? ↗

November 10, 2022

During the peak of the deadly COVID-19 pandemic, one novel therapeutic that seems to have played an important role in helping save lives was Organicell Regenerative Medicine Inc.’s (OTCMKTS:...

Via Benzinga

Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January ↗

November 09, 2022

Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.

Via Benzinga

The 7 Best Pharma Stocks to Buy Now ↗

November 08, 2022

Investors searching for gains in the current market storm should consider taking a position in some of the best pharma stocks.

Via InvestorPlace

Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next ↗

November 08, 2022

These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets.

Via The Motley Fool

BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 Outlook ↗

November 07, 2022

BioNTech doubled profit expectations in the third quarter and raised its outlook.

Via Investor's Business Daily

Meta Goes Twitter Way With Layoffs, Twitter Might Want Some People Back After Firing Them, Coal Miners Terminate $6B Combination Discussions: Top Stories Monday, Nov. 07 ↗

November 07, 2022

Wall Street Journal

Via Benzinga

BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots ↗

November 07, 2022

Via Benzinga

Risk Appetites Survive China Keeping Zero COVID Policy ↗

November 07, 2022

Chinese officials denied plans to end the zero-COVID policy and after a brief wobble, risk assets have traded better. Asia Pacific equities rallied, led by Hong Kong and mainland stocks that trade in...

Via Talk Markets

Recap: BioNTech Q3 Earnings ↗

November 07, 2022

BioNTech (NASDAQ:BNTX) reported its Q3 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings BioNTech beat estimated earnings by...

Via Benzinga

BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update

November 07, 2022

From BioNTech SE

Via GlobeNewswire

Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex ↗

November 05, 2022

Deals, financings, trials and approvals in Chinese biotech/biopharma this week.

Via Talk Markets

Did Vaccine Stocks Just Get Their Last Boost? ↗

November 04, 2022

Some positive news sent their share prices higher, but biotech companies will need to find other ways to make money.

Via The Motley Fool

This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid Boosters ↗

November 04, 2022

Pfizer and BioNTech tested their updated Covid booster against the original shot.

Via Investor's Business Daily

BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market ↗

November 04, 2022

German Chancellor Olaf Scholz agreed to allow expatriates in China to use BioNTech SE (NASDAQ: BNTX) made COVID-19 vaccine. BioNTech would be the first non-Chinese coronavirus vaccine in China, as...

Via Benzinga

Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity ↗

November 04, 2022

Via Benzinga

BioNTech Shares Up On Hope For Combined Flu, Covid Shot ↗

November 03, 2022

The shot will combine Pfizer's quadrivalent flu shot with the bivalent Covid booster.

Via Investor's Business Daily

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

November 04, 2022

From BioNTech SE

Via GlobeNewswire

Pfizer, BioNTech Launch Omicron-Adapted COVID Shot-Flu Combination Vaccine Study ↗

November 03, 2022

Via Benzinga

Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today ↗

October 28, 2022

The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.

Via The Motley Fool

November 04, 2022

From Pfizer Inc.

Via Business Wire

A New BioTech Research Race Is Focused On Improving Life For MS Patients ↗

October 27, 2022

When the world is focused on a global pandemic no one saw coming four years ago, the attention given to escalating diseases with no known cure can be hidden from the public consciousness. This is...

Via Benzinga

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com